Metraipolis › archive › dc_6aef5eb72ecb

Case Report: Ruxolitinib for systemic juvenile idiopathic arthritis complicated by macrophage activation syndrome: two pediatric cases and literature review — Europe PMC PMID:42290715

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/42290715
DOI: 10.3389/fped.2026.1812770
License (as archived): solo-consultazione
Archived: 2026-11-01T03:28:28.286Z
SHA-256 of the archived text: f607c8ce97d3fa058bcdccae4b3f7ff0051be34959217b7b5efd3db5eee43868
Stable URL of this page: https://metraipolis.com/documento/dc_6aef5eb72ecb

How to cite

Case Report: Ruxolitinib for systemic juvenile idiopathic arthritis complicated by macrophage activation syndrome: two pediatric cases and literature review — Europe PMC PMID:42290715 — Europe PMC (en), https://europepmc.org/article/MED/42290715 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_6aef5eb72ecb (Metraipolis archive dc_6aef5eb72ecb, sha256 f607c8ce97d3fa058bcdccae4b3f7ff0051be34959217b7b5efd3db5eee43868)

BibTeX

@misc{dc6aef5eb72ecb,
  title = {Case Report: Ruxolitinib for systemic juvenile idiopathic arthritis complicated by macrophage activation syndrome: two pediatric cases and literature review — Europe PMC PMID:42290715},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42290715},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_6aef5eb72ecb; sha256 f607c8ce97d3fa058bcdccae4b3f7ff0051be34959217b7b5efd3db5eee43868},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42290715. Agents can read the archived copy with the MCP tool read_document.